Susquehanna International Group
ONC

Susquehanna International Group’s BeOne Medicines Ltd ONC Stock Holding History

Susquehanna International Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Sell
7,461
-7,347
-50% -$2.16M ﹤0.01% 6350
2026
Q1 		$4.4M Buy
14,808
+11,291
+321% +$3.65M ﹤0.01% 4471
2025
Q4 		$1.07M Buy
+3,517
New +$1.15M ﹤0.01% 7031
2025
Q1 		– Sell
-11,678
Closed -$2.73M – 13693
2024
Q4 		$2.16M Buy
11,678
+8,636
+284% +$1.76M ﹤0.01% 5146
2024
Q3 		$683K Sell
3,042
-8,052
-73% -$1.45M ﹤0.01% 7718
2024
Q2 		$1.58M Buy
+11,094
New +$1.71M ﹤0.01% 5557
2023
Q4 		– Sell
-7,849
Closed -$1.42M – 13459
2023
Q3 		$1.41M Sell
7,849
-11,663
-60% -$2.31M ﹤0.01% 5862
2023
Q2 		$3.48M Buy
+19,512
New +$4.49M ﹤0.01% 4123
2023
Q1 		– Sell
-8,441
Closed -$2.02M – 13654
2022
Q4 		$1.86M Buy
8,441
+6,305
+295% +$1.16M ﹤0.01% 4847
2022
Q3 		$288K Buy
+2,136
New +$367K ﹤0.01% 9898
2022
Q2 		– Sell
-1,356
Closed -$212K – 14141
2022
Q1 		$256K Sell
1,356
-174
-11% -$37K ﹤0.01% 10663
2021
Q4 		$415K Buy
1,530
+780
+104% +$263K ﹤0.01% 9672
2021
Q3 		$272K Sell
750
-2,524
-77% -$825K ﹤0.01% 10812
2021
Q2 		$1.12M Buy
3,274
+2,691
+462% +$891K ﹤0.01% 7444
2021
Q1 		$203K Sell
583
-4,895
-89% -$1.62M ﹤0.01% 11400
2020
Q4 		$1.42M Sell
5,478
-2,302
-30% -$634K ﹤0.01% 5865
2020
Q3 		$2.23M Buy
7,780
+4,530
+139% +$1.06M ﹤0.01% 4414
2020
Q2 		$612K Sell
3,250
-46,068
-93% -$7.5M ﹤0.01% 6941
2020
Q1 		$6.07M Buy
49,318
+35,939
+269% +$5.62M ﹤0.01% 2329
2019
Q4 		$2.22M Sell
13,379
-8,640
-39% -$1.44M ﹤0.01% 4146
2019
Q3 		$2.7M Buy
22,019
+10,695
+94% +$1.42M ﹤0.01% 3683
2019
Q2 		$1.4M Buy
+11,324
New +$1.44M ﹤0.01% 4922
2018
Q3 		– Sell
-24,569
Closed -$4.13M – 10407
2018
Q2 		$3.78M Buy
+24,569
New +$4.38M ﹤0.01% 3075
2018
Q1 		– Sell
-23,546
Closed -$3.19M – 10338
2017
Q4 		$2.3M Buy
+23,546
New +$2.16M ﹤0.01% 3656
2016
Q4 		– Sell
-14,758
Closed -$455K – 10271
2016
Q3 		$455K Buy
+14,758
New +$429K ﹤0.01% 6249

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group's ONC Position: Q2 2026 in Review

Susquehanna International Group reduced its BeOne Medicines Ltd (ONC) stake by 50% in Q2 2026, selling an estimated $2.16M and leaving 7,461 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #6350.

Susquehanna International Group first reported a position in ONC in Q3 2016 and has held it in 25 quarters since. The position peaked at $6.07M in Q1 2020. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Susquehanna International Group held 7,461 shares of BeOne Medicines Ltd worth $2.13M as of Q2 2026.
  • Susquehanna International Group sold 7,347 BeOne Medicines Ltd shares in Q2 2026, an estimated $2.16M.
  • BeOne Medicines Ltd made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #6350 holding.
  • Susquehanna International Group first reported a position in BeOne Medicines Ltd in Q3 2016 and has held it in 25 quarters since.
  • Susquehanna International Group's BeOne Medicines Ltd position peaked at $6.07M in Q1 2020.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.